SI1273292T1 - Optimizirana oblika tobramicina za aerosolizacijo - Google Patents

Optimizirana oblika tobramicina za aerosolizacijo

Info

Publication number
SI1273292T1
SI1273292T1 SI200130154T SI200130154T SI1273292T1 SI 1273292 T1 SI1273292 T1 SI 1273292T1 SI 200130154 T SI200130154 T SI 200130154T SI 200130154 T SI200130154 T SI 200130154T SI 1273292 T1 SI1273292 T1 SI 1273292T1
Authority
SI
Slovenia
Prior art keywords
aerosolization
tobramycin
formulation
optimised
optimised formulation
Prior art date
Application number
SI200130154T
Other languages
English (en)
Inventor
Chiara Malvolti
Raffaella Garzia
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8177921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1273292(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of SI1273292T1 publication Critical patent/SI1273292T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SI200130154T 2001-07-02 2001-07-02 Optimizirana oblika tobramicina za aerosolizacijo SI1273292T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01116071A EP1273292B1 (en) 2001-07-02 2001-07-02 Optimised formulation of tobramycin for aerosolization

Publications (1)

Publication Number Publication Date
SI1273292T1 true SI1273292T1 (sl) 2004-12-31

Family

ID=8177921

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130154T SI1273292T1 (sl) 2001-07-02 2001-07-02 Optimizirana oblika tobramicina za aerosolizacijo

Country Status (27)

Country Link
US (5) US6987094B2 (sl)
EP (1) EP1273292B1 (sl)
JP (1) JP4262086B2 (sl)
KR (1) KR100910888B1 (sl)
CN (1) CN1234346C (sl)
AT (1) ATE267591T1 (sl)
AU (1) AU2002319226B2 (sl)
BG (1) BG66328B1 (sl)
BR (1) BRPI0211320B8 (sl)
CA (1) CA2452638C (sl)
CZ (1) CZ299348B6 (sl)
DE (1) DE60103527T2 (sl)
DK (1) DK1273292T3 (sl)
EA (1) EA006068B1 (sl)
EE (1) EE05392B1 (sl)
EG (1) EG24019A (sl)
ES (1) ES2222294T3 (sl)
HK (1) HK1068784A1 (sl)
HU (1) HU230807B1 (sl)
PL (1) PL202598B1 (sl)
PT (1) PT1273292E (sl)
SI (1) SI1273292T1 (sl)
SK (1) SK285806B6 (sl)
TN (1) TNSN03149A1 (sl)
TR (1) TR200401980T4 (sl)
WO (1) WO2003004005A1 (sl)
ZA (1) ZA200400026B (sl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
SI1273292T1 (sl) * 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimizirana oblika tobramicina za aerosolizacijo
ES2364636T3 (es) 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
EP3536344B1 (en) * 2002-03-01 2020-02-19 Chiesi Farmaceutici S.p.A. Formoterol superfine formulation
EP1673074B1 (de) * 2003-10-15 2007-01-03 PARI GmbH Spezialisten für effektive Inhalation Flüssige zubereitung enthaltend tobramycin
US8442280B2 (en) * 2004-01-21 2013-05-14 Edda Technology, Inc. Method and system for intelligent qualitative and quantitative analysis of digital radiography softcopy reading
CA2564546C (en) 2004-05-17 2013-02-26 Corus Pharma, Inc. Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) * 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP1928410A2 (en) 2005-09-29 2008-06-11 Nektar Therapeutics Antibiotic formulations, unit doses, kits, and methods
US20090246146A1 (en) * 2008-01-25 2009-10-01 Botond Banfi Halides in the treatment of pathogenic infection
LT2344129T (lt) 2008-10-07 2018-05-10 Horizon Orphan Llc Aerozolinės fluorchinolono kompozicijos, skirtos farmakokinetikų pagerinimui
SI2346509T1 (sl) 2008-10-07 2020-08-31 Horizon Orphan Llc Inhalacija levofloksacina za zmanjšanje vnetja pljuč
CN102395356A (zh) * 2009-02-18 2012-03-28 阿拉迪姆公司 pH调节的肺部给药制剂
DK2473170T3 (da) 2009-09-04 2019-08-12 Horizon Orphan Llc Anvendelse af aerosoliseret levofloxacin til behandling af cystisk fibrose
EP2388008A1 (en) 2010-05-14 2011-11-23 Combino Pharm, S.L. Stable, preservative-free, aqueous formulation for the administration by aerosolization comprising tobramycin
US8598131B2 (en) 2010-07-12 2013-12-03 Xellia Pharmaceuticals Aps Method for treatment of lung infections by administration of aminoglycosides by aerolisation
US9271993B2 (en) * 2010-09-13 2016-03-01 University Of Zurich Treatment of bacterial infectious diseases
EP4059499A1 (en) 2011-01-31 2022-09-21 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
PT2567691E (pt) 2011-09-12 2015-04-09 Pari Pharma Gmbh Composições aquosas que compreendem arbecacina
GB201208080D0 (en) 2012-05-09 2012-06-20 Norton Healthcare Ltd Tobramycin formulation
CN105534961B (zh) * 2015-12-30 2019-06-04 孙红娟 妥布霉素吸入溶液及其制备方法
CN105616345B (zh) * 2016-03-01 2018-08-21 上海方予健康医药科技有限公司 一种妥布霉素吸入组合物及其制备方法和用途
EP3551191A4 (en) * 2016-12-09 2020-09-09 EnBiotix, Inc. POTENTIALIZATION OF AMINOGLYCOSIDE FOR THE TREATMENT OF BACTERIAL PULMONARY INFECTION
CN108014099B (zh) * 2017-12-15 2019-03-01 武汉兴华智慧医药科技有限公司 一种吸入用妥布霉素溶液及其制备方法
GB2565941A (en) * 2018-11-27 2019-02-27 Norton Healthcare Ltd A process for preparing a formulation
CN113018443B (zh) * 2019-12-27 2022-09-13 海南斯达制药有限公司 治疗呼吸系统疾病的药物组合物及其制备方法
CN113952320B (zh) * 2021-09-18 2022-03-18 健康元药业集团股份有限公司 一种包含妥布霉素吸入溶液的药物组件及其用途

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
WO1992011236A1 (en) 1990-12-19 1992-07-09 Smithkline Beecham Corporation Aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
RU2114642C1 (ru) 1991-05-21 1998-07-10 Эбботт Лабораториз Аэрозольное ингаляторное устройство
AU653634B2 (en) * 1991-08-29 1994-10-06 Broncho-Air Medizintechnik Ag Medical appliance for inhaling metered aerosols
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
ES2216800T3 (es) 1991-12-18 2004-11-01 Minnesota Mining And Manufacturing Company Formulaciones de aerosol en suspension.
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
RO117414B1 (ro) 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
AU4066693A (en) 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US6042811A (en) 1993-03-17 2000-03-28 3M Innovative Properties Company Aerosol formulation containing a diol-diacid derived dispersing aid
DE69413955T2 (de) 1993-03-17 1999-04-01 Minnesota Mining & Mfg Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
CA2178473C (en) * 1993-12-20 2004-08-24 Tsi-Zong Tzou Flunisolide aerosol formulations
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
PL320856A1 (en) 1994-12-22 1997-11-10 Astra Ab Aerosol drug preparations
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
SK284448B6 (sk) * 1995-04-14 2005-04-01 Glaxo Wellcome Inc. Merací dávkovací inhalátor
SK284447B6 (sk) 1995-04-14 2005-04-01 Glaxo Wellcome Inc. Merací dávkovací inhalátor
ES2179192T3 (es) 1995-04-14 2003-01-16 Smithkline Beecham Corp Inhibidor dosificador para albuterol.
CA2218179A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for beclomethasone dipropionate
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
EP0914143A1 (en) 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
WO1998024420A1 (en) 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Pharmaceutical compositions and devices for their administration
CA2280099C (en) 1997-02-05 2005-12-27 Jago Pharma Ag Medical aerosol formulations
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
SI1273292T1 (sl) * 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimizirana oblika tobramicina za aerosolizacijo
EP3536344B1 (en) * 2002-03-01 2020-02-19 Chiesi Farmaceutici S.p.A. Formoterol superfine formulation
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
US20050083693A1 (en) * 2003-10-21 2005-04-21 Timothy Garrett Flag illumination fixture

Also Published As

Publication number Publication date
SK16432003A3 (sk) 2004-06-08
EE200400050A (et) 2004-04-15
DE60103527D1 (de) 2004-07-01
HK1068784A1 (en) 2005-05-06
PT1273292E (pt) 2004-10-29
AU2002319226B2 (en) 2006-07-06
CN1234346C (zh) 2006-01-04
EP1273292A1 (en) 2003-01-08
EG24019A (en) 2008-03-25
US7939502B2 (en) 2011-05-10
CA2452638C (en) 2010-10-05
BG66328B1 (bg) 2013-06-28
BR0211320A (pt) 2004-09-28
TNSN03149A1 (en) 2005-12-23
KR100910888B1 (ko) 2009-08-05
CN1529589A (zh) 2004-09-15
EA200301305A1 (ru) 2004-06-24
ES2222294T3 (es) 2005-02-01
KR20040018403A (ko) 2004-03-03
CZ20033580A3 (cs) 2004-10-13
US20100098642A1 (en) 2010-04-22
US20050163722A1 (en) 2005-07-28
TR200401980T4 (tr) 2004-09-21
EE05392B1 (et) 2011-04-15
US8168598B2 (en) 2012-05-01
JP2004535454A (ja) 2004-11-25
SK285806B6 (sk) 2007-08-02
CA2452638A1 (en) 2003-01-16
HUP0400387A2 (hu) 2004-09-28
US20120184502A1 (en) 2012-07-19
US7696178B2 (en) 2010-04-13
US6987094B2 (en) 2006-01-17
US20110212912A1 (en) 2011-09-01
CZ299348B6 (cs) 2008-06-25
HU230807B1 (hu) 2018-06-28
EP1273292B1 (en) 2004-05-26
DK1273292T3 (da) 2004-10-04
BG108475A (en) 2005-02-28
ZA200400026B (en) 2005-03-30
BRPI0211320B8 (pt) 2021-05-25
JP4262086B2 (ja) 2009-05-13
EA006068B1 (ru) 2005-08-25
US20040186064A1 (en) 2004-09-23
PL202598B1 (pl) 2009-07-31
BRPI0211320B1 (pt) 2015-08-18
ATE267591T1 (de) 2004-06-15
WO2003004005A1 (en) 2003-01-16
PL367139A1 (en) 2005-02-21
DE60103527T2 (de) 2005-06-16

Similar Documents

Publication Publication Date Title
HK1068784A1 (en) Optimised formulation of tobrarmycin for aerosolization
HK1126134A1 (en) Liquid formulations for the prevention and treatment of mucosal diseases and disorders
MXPA04005865A (es) Suministro de aminoglucosidos a los pulmones.
WO2002054868A3 (en) Pulmonary delivery of polyene antifungal agents
BR0012750A (pt) Agente de limpeza para superfìcies cerâmicas vìtreas
DE69511374T2 (de) Neue und verbesserte aminoglykosidformulierung als aerosol
HK1111883A1 (en) Use of a composition for preventing or treating respiratory infections and acute otitis media in infants
NZ631469A (en) Aerosol fluoroquinolone formulations for improved pharmacokinetics
ATE502623T1 (de) Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen
MX2010012452A (es) Suministro pulmonar de una fluoro-quinolona.
EP1560488A4 (en) ANTIBACTERIAL AGENTS
AR043863A1 (es) Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines
DE60307860D1 (de) Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung
CA2527365A1 (en) Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
WO2003002064A3 (en) Fused pyrimidine dhfr inhibitors as antibacterials
AU2003294565A8 (en) Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
WO2003032985A3 (en) Concomitant oral and topical administration of anti - infective agents
WO2006033713A3 (en) Methods for ciprofloxacin inhalation
BR0100228A (pt) Macrolìdeos com 13 e 14 elementos antibacterianos e procinéticos e seus intermediários
DK1157688T3 (da) Antibakterielle vandige ophthalmiske formuleringer med ofloxacin og chitosan
WO2002057281A3 (en) Aminoglycosides as antibiotics
UA27643U (en) Method for treatment of community-acquired pneumonia in children
WO2004032825A3 (en) Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax
GB0104756D0 (en) Air ioniser to prevent infections from fungus or their spores
AR022262A1 (es) Formula bactericida de amplio espectro en soluciones concentradas y diluidas